NeoGenomics (NASDAQ:NEO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does NeoGenomics (NEO) operate in?

NeoGenomics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

NeoGenomics Stock (NASDAQ: NEO) stock price, news, charts, stock research, profile.

Open	$13.61
Close	-
Volume / Avg.	295.47K / 742.73K
Day Range	13.58 - 13.87
52 Wk Range	11.03 - 21.22
Market Cap	$1.76B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	6.61%
Days to Cover	7.56

Recent News

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly dividend approximately 50% to 40 cents per share.

Avi Kapoor

Why Is Cancer Genetics Test-Focused NeoGenomics Stock Trading Higher Today?

NeoGenomics shines in Q4 2023 with an EPS turnaround to $0.03, beating estimates. Sales reach $155.55 million. CEO Chris Smith anticipates strong growth, guiding a positive fiscal 2024 outlook with an EPS forecast of $0.04.

Vandana Singh

Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Neogenomics Inc.

Sector

Health Care

Industry

Health Care Providers & Services

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United Stat...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NeoGenomics (NEO) stock?

You can purchase shares of NeoGenomics (NASDAQ:NEO) through any online brokerage.

View our list of the best stock brokerages

Who are NeoGenomics (NEO) competitors?

Other companies in NeoGenomics’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), GeneDx Hldgs (NASDAQ:WGS), Hims & Hers Health (NYSE:HIMS) and Privia Health Gr (NASDAQ:PRVA).

What is the target price for NeoGenomics (NEO) stock?

There is no analysis for NeoGenomics.

What is the forecast for NeoGenomics (NEO) stock?

NeoGenomics has a consensus price target of $20.57.

Current stock price for NeoGenomics (NEO)?

The stock price for NeoGenomics (NASDAQ: NEO) is $13.76 last updated Today at July 8, 2024 at 3:09 PM EDT.

Does NeoGenomics (NEO) pay a dividend?

There are no upcoming dividends for NeoGenomics.

When is NeoGenomics (NASDAQ:NEO) reporting earnings?

NeoGenomics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Is NeoGenomics (NEO) going to split?

There is no upcoming split for NeoGenomics.

What sector and industry does NeoGenomics (NEO) operate in?

NeoGenomics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NeoGenomics

NeoGenomics (NEO) Forecast